Cardiac Amyloidosis in Latin America: Current Situation and Perspectives

Join us for the Cardiac Amyloidosis in Latin America: Current Situation and Perspectives complimentary webinar to be conducted in Spanish (with slides in English) on Saturday, May 7 at 10:30 am (Brazil, Argentina, Uruguay) / 8:30 am CDT (Mexico) / 9:30 am EDT (Boston, USA).
Participants will receive a lesson book providing important resources to support this effort and a program evaluation to identify ongoing educational needs.
This activity is supported by an educational grant from Pfizer, Inc.
Featured Topics:
- AMILO LATAM Group Survey Results
- Epidemiology of Cardiac Amyloidosis in Latin America: Opportunities to Improve Diagnosis
- Role of Nuclear Cardiology in Cardiac Amyloidosis Diagnosis – What is Possible in Latin America
- Cardiac Amyloidosis Diagnosis Flowchart – Integration of Methods
Program Organizers
Cardiac Amyloidosis in Latin America is being organized by the Latin American Project on Cardiac Amyloidosis (AMILO LATAM) as part of the Reaching Across Latin America educational initiative designed to address ongoing knowledge, competence, and performance among HCPs across twenty countries in Latin America to enhance their skills for diagnosing and managing patients with transthyretin (ATTR) amyloidosis with the goal of improving long-term patients outcomes.
Steering Committee Members Include: Gabriel Grossman, MD, PhD, FASNC - Brazil Jorge Camilletti, MD - Argentina Isabel Carvajal, MD - Mexico Juan Erriest, MD - Argentina Fernando Mut, MD, FASNC - Uruguay Erick Alexanderson Rosas, MD - Mexico
Moderators
Gabriel Grossman, MD, PhD, FASNC Hospital Moinhos de Vento, Brazil |
Fernando Mut, MD, FASNC Hospital Italiano, Uruguay |
Faculty
Isabel Carvajal, MD |
Marcelo Di Carli, MD, MASNC |
Juan Erriest, MD |
Amalia Peix, MD, PhD, FASNC |
Agenda
.png)